A Revolution
in Oncology
The HiLight Imaging System brings next generation optical technology and AI-ML for cancer identification and margin detection with a simplified, more efficient biopsy workflows.
Prostate cancer is the leading cancer diagnosis among men, and the second most common overall
Approximately 12.9% of men will be diagnosed with prostate cancer at some point during their lifetime
Screening and biopsies are increasing diagnosis rate, leading to an increase in overall procedural volume of full or partial prostatectomy
cases diagnosed annually
>288k
>35k
deaths from prostate cancer annually
About Us
The HiLight Surgical leadership team began at the University of California, Davis. Confronted with the unmet need of tissue characterization in cancer treatment, we applied advanced biophotonics solutions to address this issue. To complement the team's scientific expertise, we retained known MedTech veterans to pivot towards commercialization.
We are now mission driven to improve the quality of care and quality of life for those who must endure the misfortune of illness and are bolstered by the knowledge that our efforts will one day change healthcare delivery and outcomes for cancer patients.
The HiLight Solution
HiLight Surgical has developed a fiber optic-based imaging system designed with the purpose of intraoperative verification of tissue margins or biopsy results immediately in real time. This simple, low-cost system utilizes label-free Fluorescence Lifetime Imaging (FLIm) technology enhanced with AI-ML.
It can operate as a stand-alone device or interface with other visualization modalities and will:
Provide immediate determination of the nature of the tumor or tissue
Deliver real time localization and discrimination of critical anatomy during surgical procedures
Potentially reduce cancer recurrence or complications associated with PSM
Improve surgical workflow with reduced procedure times and decreased cost
Improve outcomes and quality of life for the patients